<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920780/" ref="ordinalpos=2180&amp;ncbi_uid=6438567&amp;link_uid=PMC3920780" image-link="/pmc/articles/PMC3920780/figure/F2/" class="imagepopup">Figure 2.  From: In Vivo Actions of Peroxisome Proliferator-Activated Receptors. </a></div><br /><div class="p4l_captionBody">Insulin signal transduction in healthy nondiabetic (left panel) and T2DM (right panel) subjects. Thiazolidinediones improve insulin signaling through the PI-3 kinase pathway, while inhibiting insulin signaling through the MAP kinase pathway. Reprinted with permission from DeFronzo (61).</div></div>